See also this year's filing and all EDGAR filings for this company.
PDF Report 0001633932_2023_ESSA_Pharma_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001633932, ESSA Pharma Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 169,059,341 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 0 |
3 | remainder_Assets | 445,954 |
4 | LiabilitiesCurrent | 2,310,399 |
5 | LiabilitiesNoncurrent | 76,418 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 12,544,760 |
9 | ResearchAndDevelopmentExpense | 24,415,246 |
10 | remainder_Expenses | -98,075 |
11 | remainder_Revenues | 1,736,641 |
12 | remainder_NetIncome | 22,039 |
13 | remainder_ComprehensiveNetIncome | -58,666 |
yvar | yval | |
---|---|---|
0 | Assets | 169,505,295 |
1 | Liabilities | 2,386,817 |
2 | Expenses | 36,861,931 |
3 | Revenues | 1,736,641 |
4 | StockholdersEquity | 167,118,478 |
5 | NetIncome | -35,103,251 |
6 | ComprehensiveNetIncome | -35,132,584 |
7 | BaseVar | 105,285,694 |
8 | EconomicCapitalRatio | 2.94 |